The Content of Psilocybin in Norwegian Psilocybe semilanceata
Anders Christiansen, Knut Rasmussen, Klaus Høiland
Planta Medica July 1, 1981 DOI: 10.1055/s-2007-971632 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Psilocybe semilanceata mushrooms collected in Norway |
| Topics | Psilocybin |
| Keywords | Hallucinogen Mushroom Traditional medicine |
| Citations | 20 |
| Key findings | Psilocybin content in dried Norwegian Psilocybe semilanceata ranged from 0.17 to 1.96%, with higher percentage concentrations in smaller mushrooms and higher total amounts in larger mushrooms. |
Abstract
Psilocybe semilanceata contains hallucinogenic indole alkaloids and has been used as a narcotic drug in Norway. The content of psilocybin, the major constituent in Norwegian P. semilanceata, has been investigated as well as its habitats and its distribution throughout the country. The mushroom is growing on grassy sites in most parts of Norway from the middle of August to the middle of October. The psilocybin content in dried mushrooms varied considerably, from 0.17 to 1.96%. The highest concentrations in percent was found among the smaller mushrooms whereas the content in mg was highest in larger mushrooms. The content of psilocybin makes P. semilanceata to a potent hallucinogenic drug.
Comparable studies
Other observational and cohort studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Patients with treatment-resistant depression | 2017 | Observational cohort | n = 19 |
| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Healthy volunteers | 2019 | Observational cohort | n = 8 |
| Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Humans | 2017 | Observational study | |
| Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. USA adult respondents from the National Survey on Drug Use and Health (2008-2012) | 2015 | Observational cohort | n = 190,000 |
| Prediction of Psilocybin Response in Healthy Volunteers Healthy volunteers | 2012 | Observational cohort | n = 409 |
Citations in the library
Cited by 13
- Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids TemaNord May 19, 2009
- Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis Journal of Chromatography. B, Biomedical Sciences and Applications July 1, 1997
- The Quantitation of Psilocybin in Hallucinogenic Mushrooms Using High Performance Liquid Chromatography Journal of Forensic Sciences October 1, 1983
- Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes Journal of Ethnopharmacology July 1, 1994
- Champignons hallucinogènes d'Europe et des Amériques : mise au point mycologique et toxicologique Annales de Toxicologie Analytique 2004
and 8 more in the library